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ABSTRACT 
 
CAMERON G. WALKER:  Effective Dose and Image Quality of CBCT Diagnostic 
Imaging Scans 
(Under the direction of Dr. John Ludlow) 
 
To address the important issues surrounding the CBCT imaging modality we have 
initiated an investigation of CBCT dosimetry and its relation to image quality in pediatric 
and adult patients.  RANDO, ATOM adult and ATOM child phantoms were scanned with 
the i-CAT Next Generation CBCT machine at the 17x23cm field of view. Each phantom 
houses 24 optical stimulated luminescent (OSL) dosimeters or thurmolumonescent (TLD) 
dosimeters.  Dosimeter readings were used to calculate equivalent dose, effective dose and 
patient risk using 2007 ICRP guidelines.  OSL calibration and correction was verified 
using an ion chamber, NanoDot OSL dosimeters and a medical radiography system. 
Effective dose calculations ranged between 71µSv (TLD) and 65µSv (OSL) for the 
RANDO phantom and 70 and 71 for the Adult and child phantoms respectively.  Our 
results validate optical stimulated luminescent dosimeters and the ATOM phantoms as 
efficient and accurate tools to estimate the effective dose of CBCT scans.  
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I  LITERATURE REVIEW 
 
 The  use of ionizing radiation in diagnostic medical examinations has increased over 
the last 20 years to the point where the annual per capita dose to the US population from all 
sources has doubled (1). The risk of this exposure is significant, and it has been estimated 
that from 1.5% to 2% of all US cancers may be attributed to computed tomography (CT) 
studies alone (2). While CT is being used in all aspects of medical diagnosis, a dramatic 
increase in the use of cone beam CT (CBCT), a form of CT, has occurred in dentistry during 
the last decade. Some have already declared this the “gold standard” of maxillofacial imaging 
and predict that it will be used by most dental practices within the next decade(3). Along 
with many other areas of dental practice technology has found application in orthodontic 
treatment planning, which is often initiated in the pre-teen age patient(4). This is a 
particularly vulnerable group because cellular growth and organ development increases the 
radiosensitivity of tissues. In conjunction with a longer life expectancy in which cancer can 
develop, adolescents may be twice as sensitive to radiation carcinogenesis as mature 
adults(5). In addition, changes in the calculation of risk from x-ray exposures to the head and 
neck area published by the ICRP in 2007 have resulted in increases in estimated risk by as 
much as 422% from previously used 1990 calculations(6). Currently available CBCT units 
from different manufacturers have been shown to vary in dose by an order of magnitude for 
an equivalent field of view (FOV) examination. In addition, technical factor adjustments 
associated with image quality that are available in many CBCT units can cause as much as 7 
 2
fold differences in dose(6). The FDA recently advocated universal adoption of two principles 
of radiation protection: appropriate justification for ordering each procedure, and careful 
optimization of the radiation dose used during each procedure. But because aspects of device 
use and issues related to clinical decision making fall outside of its purview, the FDA is also 
encouraging complementary actions for other groups to take, which will support the FDA 
effort. Among these is the development of diagnostic reference levels both locally and 
through a national radiation dose registry(7). Because current methods of measuring radiation 
dose are largely based on adult-sized models, providing meaningful dose metrics for 
pediatric procedures can be particularly challenging. The FDA is encouraging efforts to 
improve and establish standards for pediatric dose calculations(7). Current techniques for 
measuring patient dose from CBCT examinations are either excessively complex or 
unreliable.  Simple, reliable tools to measure dose and estimate risk are urgently needed as 
these units find their way into increasing numbers of applications across the whole spectrum 
of dental practice. 
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II  INTRODUCTION 
 
 A review paper published at the end of 2007 in the New England Journal of 
Medicine (NEJM), estimated that from 1.5% to 2% of all cancers in the United States (US) 
may be attributable to the radiation from computed tomography (CT) studies(2). When the 
total number of CT examinations during the period from 1993 to 2006 are graphed, an 
exponential rise in the number of examinations far exceeding the growth in the US 
population over the same period can be appreciated(1).  In 1994 total annual effective dose of 
ionizing radiation to a person in the US was estimated at 3.60 mSv(8). Of this total, 
approximately 0.49 mSv was attributed to exposures from ionizing radiation in diagnostic 
procedures. Current estimates of per capita annual US dose are 6.20 mSv with almost 3 mSv 
coming from diagnostic procedures(1).  
Cancer is the principal long-term effect of exposure to x-rays. Evidence indicates that 
an adult exposure to x-rays as low as 90 mSv or a fetal exposure of 9-20 mSv is a cancer 
risk(9). A linear-no-threshold hypothesis of x-ray risk fits most data for cancer development, 
but extrapolation of this data must be used to estimate risks from the lower doses that are 
utilized for diagnostic imaging. The majority of scientists working in this area accept this 
extrapolation as reasonable and prudent(9). Although the risk to an individual from a single 
exam may not itself be large, millions of exams are performed each year, making radiation 
exposure from medical imaging an important public health issue. A routine CT head scan 
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may have an effective dose of approximately 2 mSv(10). CBCT examinations have been 
reported to impart a fraction of this dose; however, scans from some units approach 1 mSv, 
(11)and scans from other units have been shown to be equivalent in dose to optimized CT 
scans(6). This range of differences is especially important when considering the pediatric 
population because cellular growth and organ development is associated with increased 
radiosensitivity of tissues. In conjunction with a longer life expectancy in which cancer can 
develop, children may be two times or more sensitive to radiation carcinogenesis as mature 
adults(7,10). 
According to our published measurements, a CBCT examination might result in a 2.5 
increase in adult dose using a NewTom 3G, a low-dose unit (68 µSv) in comparison with 
conventional panoramic and cephalometric imaging (26 µSv)(12) (13).  However, other 
CBCT units and protocols may result in much higher doses to the patient. For example we 
reported a 21-fold increase in patient dose with the CB Murcuray (569 µSv) over 
conventional imaging(12). This represents a substantial increase over conventional 
alternatives for an increase in diagnostic efficacy or patient treatment efficacy that has yet to 
be demonstrated. As much as 90% of those beginning orthodontic treatment for the first time 
are pediatric patients. In comparison to adults, radiation risk is significantly greater for this 
group of patients. 
 The biological effect of exposure to ionizing radiation, expressed as the risk of cancer 
development over a lifetime, is determined from absorbed radiation dose in combination with 
other factors that account for differences in exposed tissue sensitivity and other patient 
susceptibility factors such as gender and age. Simple measurement of absorbed ionizing 
radiation does not account for sensitivity of tissues or other factors important for determining 
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risk. To address this issue the International Commission on Radiological Protection (ICRP) 
suggested in 1990 that effective dose (E) be adopted as the best means of comparing dose 
and risk from any exposure to ionizing radiation(14). Organs and tissues known to be most 
susceptible to radiation damage were assigned weights that represent the relative contribution 
of each tissue to overall risk. Effective dose, reported in Sieverts, was defined as the sum of 
the products of each tissue-weighting factor (WT) and the equivalent dose to that tissue (HT) 
or ܧ ൌ  ∑ ்ܹ ൅ ܪ்(14). Using extrapolations of cancer morbidity and mortality data 
associated with well documented exposures to large populations, such as the survivors of the 
atomic bomb explosions, radiation detriment, including the weighted probabilities of fatal 
and non-fatal cancer, can be calculated from effective dose.  
 In 2007 the ICRP published a revision of the tissues and weights used in effective 
dose calculation based on data accumulated since the original publication(9).  Of significance 
for maxillofacial imaging is an increase in the risk estimation for brain tissues and the 
addition of salivary glands, oral mucosa and lymph nodes, which may be partially or fully 
irradiated during maxillofacial examinations. These changes in the calculation of risk from x-
ray exposures to the head and neck area prescribed by ICRP have resulted in increases in 
estimated risk to adult patients by as much as 422% from previously used 1990 calculations 
(6,11,12,15,16) 
 The process of measuring dose requires a device known as a phantom. There are 
numerous design variations described in the literature or commercially available that include 
differences in phantom size, material composition, and number of dosimeters. While all 
phantoms simulate human morphology and radiation attenuation characteristics, the gold 
standard method of obtaining dosimetry for calculating effective dose requires an 
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anthropomorphic phantom. Alternate techniques for calculating dose that do not use 
anthropomorphic phantoms include CTDIvol, Air Kerma-area-product (KAP), and Dose area 
product (DAP). In a previous study comparing anthropomorphic phantom and a standard 
acrylic cylinder with a single ion chamber used to calculate (CTDIvol) we demonstrated that 
the standard acrylic cylinder underestimates effective dose by 38%-62%(6). This 
underestimation is in part due to the failure to account for scatter dose to tissues outside of 
the scan region. KAP is another method that has recently been used to calculate dose(17). 
Values reported in the referenced study underestimate effective dose measured with an 
anthropomorphic phantom in our own studies by 90% to 300%(6,15). Dose area product 
(DAP) has also been suggested as a simple approach for calculating dose. However, our 
experiments with the SCANORA 3D (Sorodex, Milwaukee, WI) unit revealed an 
approximately 3-fold change in effective dose between various locations of the small FOV 
with no change in DAP (unpublished data). In contrast, anthropomorphic phantoms made 
from materials that have similar x-ray attenuation characteristics as human tissue and have 
multiple dosimeters allow for accurate measurement of absorbed dose. In a recent study we 
confirmed that an anthropomorphic phantom using bone equivalent material in place of a 
human skeleton can provide reliable measures of effective dose(18). Overall, our review of 
the literature and findings from our previous studies indicate that the anthropomorphic 
phantom currently provides the most reliable dose measurements.  
CBCT technology and applications are developing rapidly. The applications of CBCT 
are moving beyond diagnosis to tools for treatment. Scans can now be used to fabricate 
implant surgical placement guides or used to fabricate a patient wire sequence for finishing 
an orthodontic case(19,20).  Despite rapid development and adoption by practicing clinicians, 
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dose information remains incomplete, outdated, or non-existent with no objective standards 
of image quality. To further address the important issues surrounding this rapidly developing 
imaging modality we propose a thorough investigation of CBCT dosimetry and the 
development of a simple device that may be used to inexpensively and accurately determine 
patient risk and objectively document image quality. As a first step we have undertaken the 
validation of the ATOM Adult and pediatric phantoms and optically stimulated luminescent 
dosimeters (OSL) for application in dental CBCT by comparing them to the widely used 
RANDO phantom with TLD dosimeters.  
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III  MATERIALS AND METHODS 
 
Three head and neck phantoms were used in the study  the RANDO adult skull 
(Radiation analog dosimetry system: Nuclear Associates, Hicksville, NY) , an adult male 
ATOM phantom (Model 701, CIRS, Northfolk, VA) and a 10 year-old ATOM phantom 
(Model 706, CIRS, Northfolk, VA).   To allow for dosimeter placement, each phantom was 
sectioned into 25 mm thick increments (see Figure 1). The RANDO and ATOM phantoms 
were further modified to allow for loading of the 10mm x10mm x 1.5mm NanoDotTM OSL 
chips (Launduer inc., Glenwood, IL ).  The Dosimeter locations for the RANDO phantom 
were unchanged from previous studies (6,15,21) and have been identified along with their 
corresponding level in Table 1.   Similar to the RANDO, locations for dosimeters in the 
ATOM phantoms were chosen to correspond with organs that are sensitive to ionizing 
radiation according to the 2007 ICRP recommendations(9).  The 24 dosimeter locations for 
the ATOM phantoms with their corresponding levels are listed in Table 1.   
The Next Generation i-CAT (Imaging Sciences International, Hatfield, PA) was used 
as our reference machine to compare the RANDO and ATOM phantoms as well as the OSL 
and TLD dosimetry methods.  All Next Generation i-CAT scans were administered in the 
portrait 17x23cm field of view.  The scan parameter of kV is not adjustable and is set at 
120kV for the i-CAT.  Current was set by the manufacture at 5 mA and we chose the 8.9s 
scan time for all scans (see Table 2).  
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   In the scans where the 3mm x 3mm x 1mm thermoluminescent dosimeters (TLD) 
were used, all TLDs were precalibrated, supplied and analyzed by Landauer Inc. (Glenwood, 
IL).  Optical stimulated luminescent (OSL) NanoDotTM dosimeters (Landauer Inc., 
Glenwood, IL) were cleared by exposure to a low UV emitting light source for 24 hours 
according to the manufactures instructions. The dosimeters were then read with the 
MicroStarTM reader (Landauer Inc., Glenwood, IL) (see Figure 2) to obtain baseline readings.   
The RANDO, ATOM adult, and ATOM child phantoms were loaded with dosimeters 
and scanned three times at the settings defined above.  To minimize any potential variations 
in dose an effort was made to position each phantom in the machines in a similar manner.  
The phantoms were set in position with the scan rotation parallel to the section planes, which 
in turn were approximately parallel to Frankfort horizontal, a line connecting the infraorbital 
rim to the external auditory meatus.   
After exposure, the dosimeters were removed from the phantoms and OSL dose 
information was read using the MicroStarTM reader.  The OSL dosimeters were allowed to 
stabilize for at least 10 minutes before reading. The baseline readings for each dosimeter 
were subtracted to provide the absorbed dose in mRads for each dosimeter.  Each value was 
then divided by the number of scans to provide the average absorbed dose per scan for each 
dosimeter.  Before effective dose was calculated a beam energy calibration factor was used to 
correct for variations in dosimeter sensitivity across a range of beam energies.   Average 
beam energy was estimated to be 56% of peak kV (22).  The conversion factor was then 
calculated using the following equation derived from dose response data supplied by 
Landauer(22). 
ܥ݋݊ݒ݁ݎݏ݅݋݊ ܨܽܿݐ݋ݎ ൌ   ሺ3 ൈ 10ି଺ ൈ ݔଷ െ  0.0007 ൈ ݔଶ ൅ 0.0453 ൈ ݔ ൅ 0.1005 ሻିଵ 
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where  x = average energy (keV);  Using this equation, the calibration factor for the i-CAT 
(120kV) was 1.118.  The calibration factor was multiplied directly to the absorbed dose per 
scan to obtain the corrected absorbed dose per scan.   
TLD dosimeters were sent to the manufacturer for reading (Landauer). The 
methodology was described previously (6,15), but briefly, TLD dosimeters were analyzed 
using an automatic hot gas reader. Individual chip sensitivity was used as a correction factor 
for the reading obtained from each chip.  Reported doses were divided by the number of 
scans to calculate the “exposure per scan” for each dosimeter.  
For both TLD and OSL scans, doses readings from discrete anatomical locations were 
added together and averaged to obtain an average tissue or organ dose in micrograys.  These 
values were then multiplied by the corresponding estimated percentage of the tissue or organ 
that was irradiated (see Table 3) in the examination to calculate the equivalent dose (HT) in 
microsieverts (μSv). 
For bone marrow, the weighted dose is calculated using the summation of the 
individual weighted dose to the calvarium, the mandible and the cervical spine (see Table 3).   
It is important to note the differences the proportion of the bodies bone marrow found in the 
head and neck in the adult compared to the child.  According to Cristy et al (23), the adult 
mandible contains .8% of the bone marrow, 7.7% in the calvaria and 3.7 % in the cervical 
spine totaling 12.2% of the total body bone marrow.  In contrast, the 10 year old child has 
15.4% of total body bone marrow exposed in a head and neck exam, breaking down to 1.1% 
in the mandible, 11.6% in the calvaria, and 2.7% in the cervical spine(23). As previously 
described, a correction factor based on mass energy attenuation for bone and muscle (1.97 for 
the i-CAT) was applied to the calculation of bone surface equivalent dose (6,24).   
 11
 All other proportions of tissues exposed in the head and neck exam including the 
skin, lymphatic nodes and muscle were set to be equivalent among the three phantoms. 
Following the protocol of Ludlow et al(6), the proportion of the skin surface area in the head 
and neck region directly exposed by each technique was estimated at 5% of the total body 
allowing the calculation of weighted radiation dose to the skin. Similarly muscle and 
lymphatic node exposures were estimated to represent 5% of the total body complement of 
these tissues. The proportion of the esophageal tract that is exposed was set at 10%.   
The calculation of effective dose  E=∑wT x HT expressed in μSv is the recommended 
way to compare the differential exposures to ionizing radiation to an equivalent full body 
standard(9).  The IRCP 2007 tissue weights (wT) were used to obtain weighted equivalent 
doses for all exposed organs or tissues (see Table1 and Table 3). The whole body effective 
dose E was then obtained by summing the weighted doses. 
DICOM files were saved from each scan so that the positioning of the phantom could 
be verified to help explain any potential differences in dose.  DICOM files were imported 
and analyzed using Dolphin 3D software (Dolphin imaging, Chatsworth CA). Two 
dimensional lateral cephalometric images were generated from the 3D scans to allow for 
verification of the exposure area.  
Repeated scans on using the RANDO phantom were taken to determine the precision 
of OSL dosimeter measurements. Each of the 24 dosimeter readings was compared and the 
percent variation was calculated for each and reported in a table (see Table 6).  
Verification of OSL dose readings and calibration for changes in kVp was conducted 
by exposure of 4 NanoDot dosimeters clustered around an ion chamber (model 2025, Radcal, 
Monrovia, CA) with a medical radiography system (TREX, Hologic, Marlborough, MA). 
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Four OSL dosimeters, two on each side of the ion chamber were attached to a radiolucent 
surface (25).  After exposure, the ion chamber reading was reset and the dosimeters were 
changed and different dosimeters were affixed.  The kVp was increased at intervals of 10kV 
starting at 80kV and ending at 120kV.  Current was set at a constant 125mA. Exposure time 
was reduced as kV was increased in order to keep the dose of a similar magnitude across 
each of the test conditions (see Figure 4).  Measurements from the ion chamber were 
recorded in milli-Röentgens and then converted to mRads at 1R= 0.876 Rads in air. Dose 
readings of each of the 4 OSL dosimeters were averaged together to give the average dose in 
mRad.  The calculated conversion factors for each kVp setting were multiplied by the 
average OSL dose to calculate the average corrected dose in mRad. The doses from the ion 
chamber were plotted against kVp along with the uncorrected and corrected OSL doses (see 
Figure 4). 
 The main concern for ionizing radiation is the risk of cancer.  The ICRP estimated 
cancer risk coefficient of 5.5x10-2 Sv-1 (9) was used to estimate patient risk.   
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IV  RESULTS 
 
Equivalent dose information is summarized in table 4.  Equivalent doses were highest for 
salivary gland tissues. Next highest was the oral mucosa followed by the extrathoracic airway 
and brain. The effective dose calculated for the RANDO phantom using TLDs was 71 µSv 
compared to 65 µSv when using OSL dosimeters. Effective dose was calculated to be 70 µSv 
using the ATOM adult phantom with OSL dosimeters. The ATOM child was very similar at 
71 µSv.  The reconstructed lateral cephalagrams, found in Figure 3, allow for the comparison 
of phantom position in the scans. Phantom position in the volume was similar in the RANDO 
(TLD), ATOM adult and ATOM child. In contrast, the RANDO (OSL) scan appears to be 
positioned in such a way that the posterior calvarium is not exposed in a similar way to the 
other phantoms.  
A repeat scan of the RANDO phantom using OSL dosimeters was conducted in order to 
OSL reliability.  The results of the repeated scan can be found in table 5. The percent 
variation between the first and second scan was also reported on the same table as well as the 
variation between the RANDO TLD scan and the RANDO OSL scan 1.  The variation 
between the two OSL scans was generally low.  Only two equivalent doses varied by more 
than 5%.  Esophagus had the highest variation at 16% followed by lens of the eye at 8% 
variation. The variation was much higher when comparing OSL with TLD.   Only two 
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equivalent doses varied by less than 5% and equivalent dose to bone marrow, thyroid and 
brain varied by 41%, 50%, 28% respectively.  
     When looking directly at the dosimeter readings to compare the OSL with TLD scans in 
mGy (see Table 6), the posterior calvarium had the highest variation at 119% followed by 
left calvarium, thyroid surface left, right parotid and midbrain at 73%, 60% 50% and 44% 
variation respectively. The lowest variation was in the pharynx / esophagus at 1.6% followed 
by the right cheek, right lens of eye left ramus and left orbit at 2.9%, 3.5%, 5.5% and 8.3 % 
varitation respectively. The total average variation was 14.4 percent.  
The repeated OSL scans with the RANDO phantom were compared at the dosimeter 
level (see table 6). The highest variation was 15.5% found in the esophagus followed by 
13.2% in the left mandible body and 9% variation in the left calvarium. The lowest variations 
were 0.2%, 0.9% and 1.0% in the left orbit, left back of the neck and right ramus 
respectively.  
Verification of the recommended correction for kVp was conducted using an ion 
chamber, NanoDotTM dosimeters and a medical radiography system. The decrease in 
NanoDotTM dosimeter sensitivity with the increase in kVp is demonstrated in figure 4. At 
80kV the uncorrected average OSL dose was almost identical to the dose measured by the 
ion chamber. However, the discrepancy between average OSL dose and ion dose increased as 
kVp increased.  Application of the calibration factors successfully corrected the average OSL 
dose as demonstrated in (See figure 4).   
To allow patients to grasp the relatively low risk of a CBCT examination the effective 
dose from the CBCT exam was expressed as the days of per capita background radiation.  
The  i-CAT NG 17x23 8.9s scan is the same effective dose as 11 days of background 
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radiation (see table 7). This is helpful for patients to understand. However, of primary 
interest is in the risk of developing a fatal cancer.  The probability of a fatal cancer for the 
adult is 4 in 1million, where for the child it is 12 in 1million. Divided out,  the probability is 
1 in 260,000 for an adult and one in 85,000 for the child.  
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V  DISCUSSION 
 
The most interesting of our results was the variation in equivalent and effective doses that 
we observed between OSL and TLD dosimeters (see table 5) in the RANDO phantom.  We 
identified five potential explanations for the variation between the OSL and TLD dosimeter 
scans;  1) OSL and TLD calibration and kVp correction issues  2) random error 3) radiation 
incidence angle dependence 4) machine changes that occurred in the 5 years between 2007 
and 2012 5) Phantom positioning differences. 
To explore the variation between the OSL and TLD readings we first verified our 
dosimeter calibration as well as our correction for kVp using an ion chamber, NanoDotTM 
dosimeters and a medical radiographic system.  The NanoDotTM dosimeters were optimized 
by Landauer for readings at 80kV (44keV) and need no correction at that beam energy. We 
verified the accuracy of our OSL dosimeters at 80kV using the ion chamber (Figure 4) with 
the ion dose and the average OSL dose only varying by 0.1%.  We then verified the accuracy 
of the correction factors provided by Landauer by changing kVp (see Figure 4). The 
correction factor reduced the variation from 2% to 0.8% at 120 kV. Hence, the variation 
between the 2007 TLD readings and the 2012 OSL readings cannot be explained by improper 
OSL calibration or kVp correction.  
The TLDs used for the 2007 scans were provided and analyzed by Landauer. 
Unfortunately, Landauer had since eliminated their TLD service and it was not possible to 
 17
confirm the calibration and correction process that they had in place at that time. Because we 
did not directly control the TLD calibration and reading process, it is possible that some of 
the difference between the 2007 RANDO readings and the 2012 readings may be due issues 
with the TLD process.  This highlights one of the advantages to being in control of the read 
and calibration process. 
The OSL dosimeters contain Al2O3:C discs inside the plastic housings that are 5mm in 
diameter and 0.1mm thick. It is logical to think that in a 360 degree CBCT examination 
around a stationary phantom the dosimeter would be exposed at the 0.1mm thick edge for a 
short period of time potentially reducing the sensitivity.  However, previous studies by 
Lavoei et al (25) and Jursinic (26) found negligible change in angular response when the 
dosimeters where exposed while in a head and neck phantom.  Moreover, the angular 
dependence of OSLs is equivalent to that of TLDs (26) and thus cannot be the source of the 
variation between the two.   
We also considered that there may have been a change in to the Next Generation i-CAT 
machine itself between 2007 and 2012. We used the same physical machine for our 2007 
TLD scans as well as our 2012 OSL exposures and according to the manufacture, no updates 
to the machine had occurred that would have altered the filtration or the exposure settings.  
We chose the 17x23cm FOV because it allowed for exposure of the entire head of each of 
the phantoms making the results less sensitive to variations in position.  Regardless, the most 
likely cause of a portion of the variation between the 2007 TLD and the 2012 OSL scans was 
differences in RANDO phantom positioning. The reconstructed cephalometric radiographs of 
the RANDO OSL scans demonstrated a difference in the anterior-posterior positioning of the 
phantom in the volume relative to the TLD scan(see Figure 3). To be specific, compared to 
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the RANDO TLD scan the OSL scan  appears to be positioned ~5mm more inferiorly and is 
not centered in the anterior-posterior dimension resulting in the posterior portion of the 
cranium outside the field of view.   
The equivalent doses for both OSL and TLD scans followed the same general pattern 
except for thyroid and bone marrow. Even though the TLD scan was positioned ~5mm 
higher in the volume than the OSL scan, the equivalent thyroid dose the TLD scan was 50% 
lower than the OSL measurement.  If the discrepancy in thyroid dose were due to vertical 
phantom position we would expect that the equivalent thyroid dose in the TLD scan would 
be greater than the OSL dose due to possible increased neck exposure.  Hence, the difference 
in thyroid dose may not easily be explained by variation in vertical phantom position.   
 In contrast, the 41% variation in equivalent bone marrow dose between the TLDs and 
OSLs might better be explained by phantom position. The lateral cephalometric 
reconstructions demonstrate that the posterior cranium dosimeters were out of the scan field 
of view in the OSL scans. Additionally the percent variation between the OSL and TLD 
scans by dosimeter shows a 119% difference in the posterior calvarium dosimeter. 
The reduced calvarial dose may have partially contributed to the decrease in bone marrow 
dose in the OSL scans.  However, posterior calvarial dose can only explain a maximum of 
12.5% of bone marrow dose variation leaving the remaining 28 percent of variation 
unexplained.   
 When comparing all three phantoms, a slight variation in the placement of dosimeters 
was necessary due to differences in anatomy, size and an updated understanding of tissue 
weights.   The dosimeter locations in the RANDO Phantom were selected with the ICRP 
1990 tissue weights in mind, where the ATOM phantom dosimeter locations were chosen 
 19
after the 2007 update. Thus, similar to the updated ICRP 2007 guidelines, in the updated 
ATOM phantoms, less emphasis is placed on skin surface and more dosimeters are devoted 
to the brain, bone marrow and thyroid.  The only area that shows a large difference in 
equivalent dose is the thyroid with the ATOM phantoms showing an increased thyroid dose 
relative to the RANDO (OSL).  The differences in dosimeter location, coupled with potential 
differences in size and attenuation characteristics result in a difference in soft equivalent 
doses as well as effective dose between the ATOM and RANDO phantoms.  
 As expected, the equivalent dose for bone marrow was increased in the ATOM child 
phantom relative to the ATOM adult.  Equivalent dose for brain was also increased in the 
child phantom. We postulate that the smaller size of the child allowed for a larger percentage 
of the cranium to be exposed at the 17x23cm field of view.  Increased bone marrow and brain 
equivalent doses resulted in a numerically larger effective dose in the child phantom 
compared to the ATOM adult. . Although the differences in effective dose between the adult 
and the child were small, the risk of a fatal cancer is between 3-5 times greater for a child 
than an adult.  Using the 2007 ICRP guidelines of 1 in a million cancers per 5.5x10-2 μSv (9), 
the probability of a fatal cancer for the adult was 1 in 260,000 while it was 1 in 85,000 for the 
child.   
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VI  CONCLUSIONS 
 
1.   Optically stimulated luminescent dosimeters are an accurate and repeatable tool for 
conducting dosimetry with head and neck phantoms.  
2.   Control of the TLD reading and calibration process is important to be able to explain 
variations ensure reliable dosimetry. 
3. Effective Dose for a given CBCT field of view may be increased for pediatric patients 
due to an increase in the percentage of active bone marrow and increased brain 
exposure. 
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VII. TABLES 
 
Table 1.  ICRP Tissue Weights 1990 vs 2007 
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Table 2.  Location of Dosimeters in Anthropomorphic Phantoms by Level 
 
 
 23
Table 3.  Tissue Irradiated  
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Table 4.  Equivalent and Effective Dose  
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Table 5.  Equivalent Dose and Percent Variation  
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Table 6.  OSL Dosimeter Dose and Percent Variation  
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Table 7. Cancer Risk   
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VIII. FIGURES 
 
Figure 1.  MicroStarTM Reader (A) and NanoDotTM Dosimeters (B) 
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Figure 2  Phantoms and Levels 
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Figure 3 Lateral Cephalometric View of Scans for Verification Phantom Position 
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Figure 4  Verification of OSL Calibration and Correction for Variations in kVp 
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